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Cholangiocarcinoma, renal cell carcinoma and parathyroid adenoma
found synchronously in a patient on long-term methotrexate
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Abstract
Cases of patients developing lymphoma and cutaneous neoplasms after long-term methotrexate therapy are well documented
in the literature; however, there are no reported cases of other neoplasms resulting from methotrexate therapy. A 52-year-old
woman who had been on methotrexate for 9 years for psoriatic arthritis was found to have abnormal liver function tests on
screening. Investigation with ultrasound, CT scanning and MRCP showed a hilar cholangiocarcinoma and a synchronous
right renal tumour. A left hemi-hepatectomy extended to segments 5 and 8 with the formation of a hepaticojejunostomy was
performed for a poorly differentiated infiltrative hilar cholangiocarcinoma. This was combined with a right radical
nephrectomy for a T1 renal cell adenocarcinoma. Postoperative vomiting was subsequently found to be due to
hypercalcaemia and primary hyperparathyroidism. A parathyroid adenoma was later excised. It seems likely that treatment
with methotrexate was causal in the development of these three non-cutaneous neoplasms-two malignant and one benign.
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Case report
An asymptomatic 52-year-old woman was found to
have abnormal liver function tests (LFTs) on screen-
ing after 9 years’ treatment with methotrexate (15 mg/
week) for psoriatic arthritis. Physical examination was
unremarkable. Ultrasound scanning showed dilated
intrahepatic ducts in the left liver. Her LFTs revealed:
bilirubin 14 mmol/L (normalB/17), alkaline phospha-
tase 141 U/L (normal 25/120), AST 60 U/L
(normalB/40) and CA 19/9 66 U/L (normal 0/60).
CT scanning showed dilated left-sided and right
anterior section ducts. In addition there was a lesion
in the right kidney. Magnetic resonance cholangio-
pancreatography was suggestive of a hilar cholangio-
carcinoma (Figure 1). Percutaneous biopsy of the
right kidney revealed a renal cell adenocarcinoma.
At operation a Klatskin tumour involving the left
hepatic and right anterior section duct was found
which was also invading the right branch of the portal
vein. A left hemi-hepatectomy with sleeve excision of
the right portal vein (Figure 2) was performed.
Reconstruction included a right posterior section
duct hepaticojejunostomy. Roux-en-Y and a right
radical nephrectomy were carried out.
Persistent postoperative vomiting and abdominal
pain were investigated extensively, looking for a
surgical cause. Eventually it was attributed to an
elevated calcium of 3.5 mmol/L (normal 2.10/2.55)
associated with an elevated parathyroid hormone level
of 17.8 pmol/L (normal 0.5/5.5). Treatment with
intravenous pamidronate was commenced. A nuclear
medicine scan showed a large left inferior parathyroid
gland which was excised. The calcium level decreased
from 3.15 mmol/L to 2.5 mmol/L on the first post-
operative day.
Histological examination showed a T1 renal
cell adenocarcinoma, a poorly differentiated infiltra-
tive hilar adenocarcinoma and a parathyroid ade-
noma. Chemotherapy with combination epirubicin,
cisplatinin and 5-fluorouracil was given for the
cholangiocarcinoma. She remains well 24 months
later.
Discussion
The use of methotrexate in the second-line treatment
of psoriasis [1] may be limited by hepatotoxicity
[1,2]. Coleiro and Mallia [3] studied patients on
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methotrexate and found asymptomatic elevation of
liver enzymes in 57%.
Such elevations are often transient, do not predict
liver damage and frequently return to baseline levels
even if methotrexate is continued. Dufour and Kaplan
[4] feel that such elevations are not a reason to stop
treatment and that consideration should be given to a
liver biopsy only in those patients whose serum
aminotransferase values remain elevated for more
than 2 months.
Several studies have documented the develop-
ment of squamous cell carcinomas in psoriatic
patients on psoralen with ultraviolet A (PUVA) and
methotrexate [5]. Zumtobel and co-workers [6]
showed that methotrexate was an additional factor
independent of PUVA that contributed to squamous
cell carcinoma development, and they advised caution
in starting methotrexate in patients who had been
exposed to high doses of PUVA. While lymphoma
resulting from methotrexate treatment is well docu-
mented in the literature [7], a Medline search did not
reveal any reports of non-cutaneous methotrexate-
induced carcinogenesis other than lymphoma. The
case described appears to demonstrate the develop-
ment of multiple neoplasms with long-term metho-
trexate use.
Figure 1. MRCP scan showing dilatation of the left intrahepatic ducts.
Figure 2. Hilum and underside of extended left hepatectomy specimen.
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Abstract
Idiopathic fibrosing pancreatitis has been associated with Sjo¨gren’s syndrome, primary biliary cirrhosis and primary
sclerosing cholangitis. This condition frequently develops in childhood and youth, and has also been related to ulcerative
colitis and pericholangitis. Pancreatic complications have been rarely described as systemic complications of ulcerative
colitis. A 25-year-old man presented with epigastric pain and jaundice. Abdominal ultrasonography, computed tomography
(CT), magnetic resonance cholangiopancreatography (MRCP) and endoscopic retrograde cholangiopancreatography
(ERCP) revealed a diffuse enlargement of the pancreas, filiform distal stenosis of the common bile duct and intrahepatic bile
ducts, and pancreatic duct dilatation. At operation, a rock-hard and nodular pancreas was noted. Cholecystectomy and
Roux-en-Y hepaticojejunostomy, with an access loop, was successfully performed. Idiopathic fibrosing pancreatitis should
be considered in young patients with obstructive jaundice, especially those affected with chronic inflammatory or
autoimmune diseases. Glucocorticoid therapy would be the first-line treatment, although many patients require operation.
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Introduction
Extra-colonic complications of ulcerative colitis can
involve many organs, including liver, biliary tract,
joints, eyes and skin. We present a case of obstructive
jaundice secondary to a fibrosing pancreatitis asso-
ciated with ulcerative colitis; complete symptomatic
recovery followed surgical treatment.
Case report
A 25-year-old man was admitted with epigastric pain
and jaundice. He had a 4-year history of ulcera-
tive colitis demonstrated by colonic biopsy. Acute
attacks of colitis had been treated with 5-aminosali-
cylate. There was no family history of pancreatic
disease, hepatic disorders or inflammatory intestinal
disease. Laboratory data revealed a total bilirubin
of 195 mmol/L (normalB/18), an alkaline phosphatase
of 1010 U/L (normalB/129), a gamma-glutamyl
transpeptidase of 214 U/L (normalB/61), SGOT of
184 U/L (normalB/37) and SGPT of 502 U/L
(normalB/40). Hepatitis serology was negative. IgG
levels were normal.
Ultrasonography revealed dilatation of the main bile
duct and pancreatic duct. An ill-defined nodule was
seen at the pancreatic head. Abdominal CT revealed
intrahepatic and extrahepatic dilatation of the upper
biliary tract, plus pancreatic duct dilatation and a
homogeneous enlargement of the head of pancreas
(Figure 1). The patient underwent endoscopic retro-
grade cholangiopancreatography (ERCP) (Figure 2)
and magnetic resonance cholangiopancreatography
(MRCP) (Figure 3), which revealed a filiform distal
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